Back to Search
Start Over
Drug-induced Sweet's syndrome secondary to hepatitis C antiviral therapy.
- Source :
- International Journal of Dermatology; Sep2008, Vol. 47 Issue 9, p957-959, 3p, 2 Color Photographs
- Publication Year :
- 2008
-
Abstract
- Pegylated interferon-alpha in combination with ribavirin currently represents the therapeutic standard for the hepatitis C virus infection. Interferon based therapy may be responsible for many cutaneous side effects. We report a case of drug-induced Sweet's syndrome secondary to hepatitis C antiviral therapy. To our knowledge, this is the first reported case of Sweet's syndrome in association with pegylated interferon-alpha therapy. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00119059
- Volume :
- 47
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- International Journal of Dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 33864768
- Full Text :
- https://doi.org/10.1111/j.1365-4632.2008.03724.x